Close

Roth Capital Keeps Cerulean Pharma (CERU) at 'Buy' Amid Capital Raise, Key Collaboration with Novartis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. GM
2. SPY
3. TSLA
4. SHW
5. SPOT
6. AAPL
7. NVDA
8. AMZN
9. MINN
10. MTTR


Go back to Roth Capital Keeps Cerulean Pharma (CERU) at 'Buy' Amid Capital Raise, Key Collaboration with Novartis
CERULEAN PHARMA (NASDAQ: CERU) Delayed: 0.66 --0 (-0%)
Previous Close $0.66    52 Week High $4.33 
Open $8.29    52 Week Low $0.63 
Day High $0.66    P/E N/A 
Day Low $0.66    EPS $0.00 
Volume 97,258